Cyteir Leadership 2020-04-14T11:14:56+00:00

Cyteir Leadership


Markus Renschler, MD
Markus Renschler, MDPresident and Chief Executive Officer
Barbara Wan, PhD
Barbara Wan, PhDVP, Research and Development Project Leadership
Jean-Marc Lapierre, PhD
Jean-Marc Lapierre, PhDVice President of Chemistry
Susan Doleman
Susan DolemanVP, Clinical Operations
Tom O'Shea, PhD
Tom O'Shea, PhDVice President of Preclinical Development
Andrew Gengos
Andrew GengosChief Business Officer

“It is with patients in the forefront of our minds that we work diligently to develop novel gain of function synthetic lethal therapies”

Melinda Anne Lynch Day, PhD – Principal Scientist, Cyteir Therapeutics, Inc.